Cyclenium Pharma is currently raising additional financing to further develop their internal programs and expand their proprietary CMRT macrocyclic platform technology.

We will be in attendance at the following events this year:

BIOTECanada Investor Summit
(February 26-28, Whistler, BC)

Drug Discovery Chemistry 2016 
(April 19-22, San Diego, CA)

Mastering Medicinal Chemistry 2016 
(June 15-16, Boston, MA)

Redefining Early Stage Investments (RESI) Conference
(June 23, Toronto, Ontario, Canada)

(November 7-9, Cologne, Germany)

Please contact Dr. Helmut Thomas for a complete overview of the opportunities that an investment in Cyclenium Pharma can offer.